Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT02469415 · TERMINATED
Trial details
- NCT number
- NCT02469415
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-30
- Primary completion
- 2017-06-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.